H Farkas-Himsley - JoVE Visualize

Showing results (11-20 of 17) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 17 results.

Cancer Research|May 1, 1982

Variants of an interspecies hybridoma with altered tumorigenicity and protective ability against mouse myeloma tumorsR Baumal, E Musclow, H Farkas-Himsley, et al.

Cytobios|January 1, 1991

Fluorescence assay to monitor phagocytosis by blood-clot derived polymorphonuclear leucocytes. 1. Study of patients with diabetes and phagocytosis of different staphylococcal speciesC E Musclow, H Farkas-Himsley, G Durbahn, et al.

Cellular and Molecular Biology (Noisy-Le-Grand, France)|August 1, 1992

Partially purified bacteriocin kills malignant cells by apoptosis: programmed cell deathH Farkas-Himsley, Y S Zhang, M Yuan, et al.

European Journal of Cancer & Clinical Oncology|April 1, 1987

Acute lymphoblastic leukemia of childhood monitored by bacteriocin and flowcytometryC E Musclow, H Farkas-Himsley, S S Weitzman, et al.

Anticancer Research|May 1, 1994

Augmentation of interleukin-6 (IL-6) expression in squamous carcinoma cells and normal human keratinocytes treated with recombinant anti-neoplastic protein (ACP)R C McKenzie, T J Venner, D N Sauder, et al.

Proceedings of the National Academy of Sciences of the United States of America|July 18, 1995

The bacterial colicin active against tumor cells in vitro and in vivo is verotoxin 1H Farkas-Himsley, R Hill, B Rosen, et al.

Cytobios|January 1, 1991

Fluorescence assay to monitor phagocytosis by bloodclot derived polymorphonuclear leucocytes. 2. Study of patients with psoriasis and the effect of exposing leucocytes to psoriatic skin scalesC E Musclow, H Farkas-Himsley, R Kanee-Schachter, et al.

Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 17 results.

Cancer Research|May 1, 1982

Variants of an interspecies hybridoma with altered tumorigenicity and protective ability against mouse myeloma tumorsR Baumal, E Musclow, H Farkas-Himsley, et al.

Cytobios|January 1, 1991

Fluorescence assay to monitor phagocytosis by blood-clot derived polymorphonuclear leucocytes. 1. Study of patients with diabetes and phagocytosis of different staphylococcal speciesC E Musclow, H Farkas-Himsley, G Durbahn, et al.

Cellular and Molecular Biology (Noisy-Le-Grand, France)|August 1, 1992

Partially purified bacteriocin kills malignant cells by apoptosis: programmed cell deathH Farkas-Himsley, Y S Zhang, M Yuan, et al.

European Journal of Cancer & Clinical Oncology|April 1, 1987

Acute lymphoblastic leukemia of childhood monitored by bacteriocin and flowcytometryC E Musclow, H Farkas-Himsley, S S Weitzman, et al.

Anticancer Research|May 1, 1994

Augmentation of interleukin-6 (IL-6) expression in squamous carcinoma cells and normal human keratinocytes treated with recombinant anti-neoplastic protein (ACP)R C McKenzie, T J Venner, D N Sauder, et al.

Proceedings of the National Academy of Sciences of the United States of America|July 18, 1995

The bacterial colicin active against tumor cells in vitro and in vivo is verotoxin 1H Farkas-Himsley, R Hill, B Rosen, et al.

Cytobios|January 1, 1991

Fluorescence assay to monitor phagocytosis by bloodclot derived polymorphonuclear leucocytes. 2. Study of patients with psoriasis and the effect of exposing leucocytes to psoriatic skin scalesC E Musclow, H Farkas-Himsley, R Kanee-Schachter, et al.

Pageof 2